Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age19+
SponsorHuons Co., Ltd.
About this trial
A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertension
Eligibility criteria
Qualifiers
Adults aged 19 years and older
Participants diagnosed with POAG or OH
Have fully explained and understood the study and have voluntarily given written informed consent.
Disqualifiers
Acute or chronic angle-closure glaucoma
Congenital glaucoma, secondary glaucoma (open-angle glaucoma)
Trial design
Treatments tested in this trial
- HUC3-637
- HUC3-637-R
Treatment groups
206 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov